Gisselbaek, Mia
Suppan, Mélanie
Minsart, Laurens
Köselerli, Ekin
Nainan Myatra, Sheila
Matot, Idit
Barreto Chang, Odmara L.
Saxena, Sarah
Berger-Estilita, Joana
Article History
Received: 9 September 2024
Accepted: 15 October 2024
First Online: 11 November 2024
Declarations
:
: On April 16, 2024, an ethical committee waiver (Req-2024-00531) was obtained from the Swissethics—University of Bern, Switzerland. The researchers followed the Data Protection Acts and the study complied with the Declaration of Helsinki []. The study adhered to the strengthening the reporting of observational studies in epidemiology (STROBE) reporting guideline. []
: Not applicable.
: OB received funding from the Harold Amos Medical Faculty Development Program and participated as an investigator for the clinical trial OLIVER from Medtronic<sup>®</sup>. SS has received speaker’s fees from Medtronic<sup>®</sup>/Merck<sup>®</sup>. JB-E is a member of the European Society of Anesthesiology and Intensive Care (ESAIC) Board of Directors and has received speaker fees from Medtronic<sup>®</sup>. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.